Rejuvel Bio-Sciences, Inc.
NUUU
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -286.93% | -136.70% | 89.75% | 163.48% | 213.47% |
| Total Depreciation and Amortization | 33.33% | 53.85% | 66.67% | 136.36% | 50.00% |
| Total Amortization of Deferred Charges | -- | 995.83% | -85.97% | 100.00% | -100.00% |
| Total Other Non-Cash Items | 91.03% | 113.49% | -92.97% | -459.69% | -4,571.08% |
| Change in Net Operating Assets | 311.92% | 66.67% | -626.40% | 64.05% | 400.00% |
| Cash from Operations | 40.98% | -119.67% | -40.44% | -43.59% | -75.87% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -50.00% | -- |
| Total Debt Issued | 11.45% | -- | -- | -- | 100.68% |
| Total Debt Repaid | -149.54% | -- | -- | 28.87% | -- |
| Issuance of Common Stock | -100.00% | -87.73% | -63.76% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.98% | -57.85% | -100.96% | -96.45% | -889.89% |
| Cash from Financing | -62.47% | 217.21% | -47.02% | -155.72% | 103.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -244.08% | 53.17% | -97.80% | -49,566.67% | 360.61% |
